chemotherapy induced neuropathy. Drug-induced polyneuropathy
Conditions
Interventions
Intervention 1: Intervention group: receiving medical treatment including 300 mg gabapentin capsules and vitamin B1 tablets for 6 weeks + high-power laser treatment in the soles of the feet for 6 week
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: diagnosed with breast cancer Under chemotherapy with taxane drugs Currently, the disease is under control. Chemotherapy is over A month has passed since the end of chemotherapy she is suffering from chemotherapy induced neuropathy.
Exclusion criteria
Exclusion criteria: Metastatic breast cancer Under multidrug chemotherapy Before starting chemotherapy, have a history of neuropathy, such as diabetic neuropathy Have a history of spinal canal stenosis and disk herniation. Having diseases such as diabetes that can cause neuropathy complications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neuropathy score based on mTNS criteria. Timepoint: At the beginning of the study - at the end of the intervention - one month after the end of the intervention. Method of measurement: modified Total Neuropathy Score.;Neuropathy score based on CINQ questionnaire. Timepoint: At the beginning of the study - at the end of the intervention - one month after the end of the intervention. Method of measurement: chemotherapy-induced neurotoxicity questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSina Fadaei Tehrani
Esfahan University of Medical Sciences
Outcome results
None listed